Richard S Nicholas - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Richard S Nicholas

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Journal of Neuroinflammation|January 4, 2012

Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Pascal F Durrenberger, Anna Ettorre, Fatemah Kamel, et al.

Age and Ageing|April 23, 2020

Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trialMiles D Witham, Clare L Clarke, Anita Hutcheon, et al.

European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2016

Kinetic analysis of the translocator protein positron emission tomography ligand [<sup>18</sup>F]GE-180 in the human brainClaire Feeney, Gregory Scott, Joel Raffel, et al.

Neurology|July 13, 2021

Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022

Measuring coping in multiple sclerosis: The Coping Index-MSCarolyn A Young, Roger J Mills, Dawn Langdon, et al.

Radiology|May 2, 2018

Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR AngiographyMatthew A Lambert, Jonathan R Weir-McCall, Marco Salsano, et al.

Neurology|October 3, 2022

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With ImagingRosa Cortese, Ferran Prados Carrasco, Carmen Tur, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|May 1, 2025

Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple SclerosisDamiano Marastoni, Elisa Colato, Matteo Foschi, et al.

Neurology|October 6, 2021

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022

Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 SeveritySteve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Journal of Neuroinflammation|January 4, 2012

Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Pascal F Durrenberger, Anna Ettorre, Fatemah Kamel, et al.

Age and Ageing|April 23, 2020

European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2016

Kinetic analysis of the translocator protein positron emission tomography ligand [<sup>18</sup>F]GE-180 in the human brainClaire Feeney, Gregory Scott, Joel Raffel, et al.

Neurology|July 13, 2021

Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022

Measuring coping in multiple sclerosis: The Coping Index-MSCarolyn A Young, Roger J Mills, Dawn Langdon, et al.

Radiology|May 2, 2018

Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR AngiographyMatthew A Lambert, Jonathan R Weir-McCall, Marco Salsano, et al.

Neurology|October 3, 2022

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With ImagingRosa Cortese, Ferran Prados Carrasco, Carmen Tur, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|May 1, 2025

Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple SclerosisDamiano Marastoni, Elisa Colato, Matteo Foschi, et al.

Neurology|October 6, 2021

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022

Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 SeveritySteve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.

Pageof 2